Innovent and Lilly seemingly committed some unforced errors in how they conducted the ORIENT trial and brought the results to the US FDA. • Source: Alamy
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
